Dr. Vance Merhoff, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,413 | 96 | 67.7% |
| Current or prospective ownership or investment interest | $668.93 | 1 | 32.1% |
| Education | $4.69 | 1 | 0.2% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Physician Discoveries, LLC | $668.93 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $490.72 | 39 | $0 (2018) |
| PFIZER INC. | $152.42 | 11 | $0 (2018) |
| Janssen Biotech, Inc. | $151.36 | 9 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $115.50 | 7 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $102.30 | 7 | $0 (2018) |
| Amgen Inc. | $83.43 | 5 | $0 (2018) |
| AbbVie, Inc. | $67.83 | 5 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $54.64 | 3 | $0 (2018) |
| Rochester Medical Corporation | $48.48 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $655.07 | 46 | Astellas Pharma US Inc ($216.43) |
| 2017 | $1,431 | 53 | Physician Discoveries, LLC ($668.93) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Endocrinology | ||||||
| 11/26/2018 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: UROLOGY | ||||||
| 11/20/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2018 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: UROLOGY | ||||||
| 11/12/2018 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: UROLOGY | ||||||
| 11/01/2018 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 10/30/2018 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Oncology | ||||||
| 10/17/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: UROLOGY | ||||||
| 10/10/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Endocrinology | ||||||
| 10/04/2018 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: UROLOGY | ||||||
| 09/25/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2018 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Endocrinology | ||||||
| 09/04/2018 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 08/28/2018 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 08/22/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: UROLOGY | ||||||
| 08/07/2018 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: UROLOGY | ||||||
| 07/31/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2018 | Mission Pharmacal Company | Urocit-K (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Urological | ||||||
| 07/13/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: UROLOGY | ||||||
| 07/12/2018 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 07/10/2018 | Janssen Biotech, Inc. | Erleada (Drug), Erleada | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 06/28/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: UROLOGY | ||||||
| 06/04/2018 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 57 | 63 | $7,842 | $1,925 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $5,964 | $1,683 | 28.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 12 | 15 | $1,215 | $117.09 | 9.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 18 | 21 | $303.25 | $72.66 | 24.0% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 13 | 13 | $360.00 | $51.78 | 14.4% |
About Dr. Vance Merhoff, MD
Dr. Vance Merhoff, MD is a Urogynecology and Reconstructive Pelvic Surgery healthcare provider based in Salisbury, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235112897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vance Merhoff, MD has received a total of $2,087 in payments from pharmaceutical and medical device companies, with $655.07 received in 2018. These payments were reported across 99 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,413).
As a Medicare-enrolled provider, Merhoff has provided services to 57 Medicare beneficiaries, totaling 63 services with total Medicare billing of $1,925. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Practice Information
- Specialty Urogynecology and Reconstructive Pelvic Surgery
- Location Salisbury, NC
- Active Since 11/28/2005
- Last Updated 10/08/2019
- Taxonomy Code 2088F0040X
- Entity Type Individual
- NPI Number 1235112897
Products in Payments
- Myrbetriq (Drug) $274.29
- XTANDI (Drug) $168.93
- MYRBETRIQ (Drug) $131.43
- ZYTIGA (Drug) $106.33
- XIAFLEX (Biological) $102.30
- Prolia (Biological) $83.43
- FIRMAGON (Drug) $81.86
- Xofigo (Drug) $54.64
- Erleada (Drug) $45.03
- TOVIAZ (Drug) $38.65
- Androgel (Drug) $37.61
- NOCDURNA (Drug) $33.64
- UroLift (Device) $31.73
- Lupron (Drug) $30.22
- VIAGRA (Drug) $29.84
- Natesto (Drug) $19.58
- GENERAL - ERECTILE DYSFUNCTION (Device) $18.45
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $18.45
- BPV-MaxCore (Device) $14.08
- LoFric (Device) $13.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.